Stevanato group initiates construction on new u.s. facility

Piombino dese (pd), italy--(business wire)--stevanato group (nyse:stvn), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced that it will begin construction on its new u.s. facility in fishers, indiana, this month. the site, expected to be operational in 2023, is expected to enable stevanato group to be in closer proximity to its north america pharmaceutical customers and to provide an a
STVN Ratings Summary
STVN Quant Ranking